Product Images Oxcarbazepine

This text provides statistical information related to the exit rate based on a log-rank test with a p-value of 0.0001, comparing treatment groups of Oxcarbazepine and Placebo over a trial period from Day 2 to Day 11.*

The given text provides information about the seizure rate study, including the result of the log-rank test with a p-value of 0.046 and a table showing days from the first dose to the first seizure in the treatment groups Oxcarbazepine and Placebo. This data could be related to a clinical trial or a pharmaceutical study.*

The text provides statistical information on exit rate using the log-rank test with a p-value of 0.0001. The graph displays time to exit in days based on treatment groups, with a notable difference in the exit rate between the treatment groups identified as "Grot" and "HIGH ow".*

Each film-coated tablet contains 150 mg of oxcarbazepine. It is recommended to refer to the insert for dosage and complete product information. The medication may contain FD&C Yellow No. 5 as a color additive. Store between 20°C-25°C (68°F); excursion permitted to 15°C-30°C (59°F-86°F). Dispense in a tight container. This medication is available in a package of 100 tablets. Distributed by Breckenridge Pharmaceutical, Inc. and manufactured by Towa Pharmaceutical Europe, S.L. It is essential to keep this and all medication out of the reach of children.*

Each film-coated tablet of oxcarbazepine contains 300 mg of the active ingredient. This medication guide provides important information regarding dosage and product details. The tablets may contain FD&C Yellow No. 5 as a color additive. Storage instructions include keeping the tablets at 20%-25°C (77°F). Oxcarbazepine is dispensed in a tight container as per USP guidelines. The product is distributed by Breckenridge Pharmaceutical, Inc., and manufactured by Towa Pharmaceutical Europe, S.L. It is essential to keep this medication out of the reach of children.*

Each film-coated tablet contains 600 mg of oxcarbazepine. The dosage information and complete product details can be found in the insert included with the medication. It is advised to print Medication Guides from the website mentioned for more information. The tablets contain FD&C Yellow No. 5 as a color additive and should be stored at 20°-25°C (77°F) with excursions permitted to 15°-30°C (50°-86°F) as per USP guidelines. Dispensing should be done in a tight container. The product is labeled with NDC 51991-055-01 and is manufactured by Towa Pharmaceutical Europe, S.L. in Spain. It is distributed by Breckenridge Pharmaceutical, Inc. in Berkeley Heights, NJ. Remember to keep this medication out of the reach of children.*